New potent and selective tankyrase inhibitors for the treatment of disease or conditions associated with Wnt signalling e.g. colon cancer, prostate cancer, idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and type-1/type-2 diabetes.

Nathubhai, Amit, Threadgill, M D (2016) New potent and selective tankyrase inhibitors for the treatment of disease or conditions associated with Wnt signalling e.g. colon cancer, prostate cancer, idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and type-1/type-2 diabetes. WO2017-GB52624.

This is the latest version of this item.

Full text not available from this repository.

Search Google Scholar

Item Type: Patent
Subjects: Sciences > Chemistry
Divisions: Faculty of Health Sciences and Wellbeing
Faculty of Health Sciences and Wellbeing > School of Pharmacy and Pharmaceutical Sciences
Depositing User: Amit Nathubhai
Date Deposited: 10 Aug 2018 13:52
Last Modified: 18 Dec 2019 16:07
URI: http://sure.sunderland.ac.uk/id/eprint/9804

Available Versions of this Item

Actions (login required)

View Item View Item